Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine receptor
acetylcholine receptor antibody
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
alemtuzumab
algorithm
amphiphysin antibodies
ANA
anti MAG antibodies
anti Ro antibody
area postrema
area postrema syndrome
ascending paralysis
asymptomatic
atypical
autoantibodies
autoimmune disease
azathioprine
basal ganglia
basal ganglia, lesion of
biologic markers
blindness
blindness, sudden
brain biopsy
brainstem, lesion of
bulbar palsy
central vein sign
cerebellar lesion
cerebral arteries
cerebral cortex
cerebral edema
cerebral edema, vasogenic
cerebral vasculature
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal bands, absent
cerebrospinal fluid, oligoclonal IgG in
children
chorioretinitis
chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
Clinical Pathologic Conference(C.P.C.)
collapsin response mediator protein 5 IgG
coma
comorbidities
complications
concentric sclerosis
confusion
conus medullaris vs.cauda equina lesion
conus medullaris, lesion of
corpus callosum
corpus callosum, lesion of
cost
critical care unit
cytokines
cytomegalovirus infection
daclizumab
deep gray nuclei
demyelinating disease
dermatomyositis
diagnostic criteria
diencephalon
differential diagnosis
diplopia
disability, neurological
dysarthria
eculizumab
efficacy
electroencephalogram, abnormalities of
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalomyelitis
encephalopathy
epidemiology of neurology
eye, pain in
false negative
false positive
familial
fatigue
fever
fourth ventricle, floor
gadolinium
gammaglobulin therapy, intravenous
gender
Guillain Barre syndrome
headache
hemiparesis
heralding manifestation
hiccoughs
hiccoughs, intractable
HLA
hypersomnia
hyperthermia
hyponatremia
hyponatremia with cerebral disorders
hypothalamus
hypothalamus, damage to
hypothalamus, lesion of
iatrogenic neurologic disorders
idiopathic
immunohistochemistry
immunomodulation
immunosuppressive agents
immunotherapy
inappropriate antidiuretic(A.D.H.)hormone
inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with
inebilizumab
infection
infliximab
intellectual deterioration
internal capsule
intracerebral hemorrhage
Japan
jaw claudication
level of consciousness, decreased
limbic encephalitis
linear lesion
lipoprotein receptor-related protein 4
lumbosacral radiculopathy
mammillary bodies
medulla oblongata
medulla oblongata, lesion of
meningeal enhancement
mental status, abnormal
microangiopathy, spinal cord
mimics
misdiagnosis
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, cloud-like
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, negative
MRI, optic nerve
MRI, spinal cord
MRI, spinal cord, increased intramedullary cord signal
MRI, target sign
MRS
multiple sclerosis
multiple sclerosis, differential diagnosis of
multiple sclerosis, misdiagnosis
multiple sclerosis, spinal form
multiple sclerosis, treatment of
multiple sclerosis, tumefactive
muscle weakness
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, ocular
myasthenia gravis, receptor site in
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, variants
myasthenic crisis
myelitis
myelitis, autoimmune
myelitis, longitudinal
myelitis, transverse
myelitis, transverse, idiopathic
myelitis, transverse, recurrent
myelopathy
myelopathy, ischemic
myeloradiculitis
myocarditis
natalizumab
nausea and vomiting
negative
neurologic disease, diagnoses of
neurologic disease, multiple
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuromyelitis optica (Devic's disease), screening
neuromyelitis optica spectrum disorder
neuromyelitis optica, IgG
neuropathology
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, peripheral, treatment
NMDA antagonists
old age, neurology of
ophthalmoplegia
opportunistic infection
optic chiasm
optic chiasm, lesion of
optic nerve
optic nerve, enhancement
optic nerve, lesion of
optic neuritis
optic neuritis, alternating
optic neuritis, bilateral
optic neuritis, recurrent
optical coherence tomography
pain, back
paraparesis, flaccid
Parkinsonism syndrome
periaqueductal lesion
perseveration
plasmapheresis
pleocytosis of cerebrospinal fluid
polymyositis
polyneuropathy, chronic inflammatory demyelinating
pons, lesion of
posterior leukoencephalopathy syndrome
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
ptosis
ptosis, bilateral
quadriparesis
quality of life
radiculitis
recurrent
Red flags
remission
remote effect of cancer on the nervous system
respirator
respiratory failure
retinal lesion
review article
rituximab
safety
sarcoidosis
sarcoidosis, CNS
scalp tenderness
screening
sedimentation rate, elevated
seizure
sensory level
serologic testing
serologic testing of cerebrospinal fluid
serologic testing, false negative
seronegative
seropositive
Sjogren's syndrome
somnolence
spinal cord, compression of
spinal cord, lesion of
spinal cord, neoplasm
splenium of corpus callosum
steroid
steroid therapy, CNS treatment and complications with
subarachnoid hemorrhage
sweet taste
symmetric brain lesions
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
temporal lobe, lesion
temporal lobe, lesion, bilateral
thalamus, lesion of
thalamus, lesion of-bilateral
third ventricle, wall
thymectomy
thymic hyperplasia
thymoma
thyroiditis
tonic spasms
toxoplasma gondii
transient neurologic deficit
treatment of neurologic disorder
tumefactive lesion
urinary retention
vision loss, sequential
vision, blurred
visual acuity
visual loss
visual loss, progressive
visual loss, sudden
vomiting, intractable
water channel antibodies
weakness
weakness, fatiguable
weakness, generalized
white matter disease
white matter disease, periventricular
whites
workup
Showing articles 0 to 50 of 1433 Next >>

Differentiating Multiple Sclerosis from AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease with Imaging
Neurol 100:e308-e323, Cortesa,R.,et al, 2023

Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
Neurol 100:e1418-e1432, Cacciaguerra, L.,et al, 2023

A New Case of Neuromyelitis Optica Spectrum Disorders with Unknown Fever and Subacute Cognitive Decline with Normal Images
Cureus 14:e24950, Furuya,K. & Itoh,M., 2022

Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022

Intracerebral Hemorrhage in Patients with Neuromyelitis Optica:Case Report with Literature Review for Possible Pathological Association
Case Rep Neurol 13:157-165, Elshony,H.S.,et al, 2021

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
Neurol 97:e1351-e1358, Zhao-Fleming,H.H.,et al, 2021

Pregnancy in Patients with AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder
Neurol 96:e2006-e2015, Collongues, N.,et al, 2021

Sequential Bilateral Vision Loss in a Woman with Scalp Tenderness and Jaw Claudication
JAMA Neurol 78:878-879, Kaufman, A.R.,et al, 2021

Second Drug Okayed for Rare Central Nervous System Disease
JAMA 324:224, Jaklevic, M.C., 2020

Aquaporin-4 and MOG Autoantibody Discovery in Idiopathic Transverse Myelitis Epidemiology
Neurol 93:e414-e420, Sechi, E.,et al, 2019

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
NEJM 381:614-625, Pittock, S.J.,et al, 2019

Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder (N-MOmentum): A Double-Blind, Randomised Placebo-Controlled Phase 2/3 Trial
Lancet 394:1352-1363,1304, Cree, B.A.C.,et al, 2019

Evaluation of Idiopathic Transverse Myelitis Revealing Specific Myelopathy Diagnoses
Neurol 90:e96-102, Zalewski, N.L.,et al, 2018

Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
JAMA Neurol 75:65-71, Hamid, S.H.M.,et al, 2018

Area Postrema Syndrome
Neurol 91:e1642-e1651, Shosha, E.,et al, 2018

A Man with Rapidly Ascending Paralysis
Neurol 89:e25-e31, Rosenberg, J.,et al, 2017

A Patient with a History of Encephalomyelitis and Recurrent Optic Neuritis
Neurol 89:e231-e234, Gutman, J.M.,et al, 2017

Clinical Presentation and Prognosis in MOG-antibody Disease: A UK Study
BRAIN 140:3128-3138, Jurynczyk, M.,et al, 2017

A 50-year-old Woman with SLE and a Tumefactive Lesion
Neurol 89:e140-e145, Choi, J.H.,et al, 2017

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Neuromyelitis Optica Spectrum Disorders
UpToDate, May, Glisson,C.C., 2016

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
J Clin Neurol 12:515-516, Hsu,C-L.,et al, 2016

International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
Neurol 85:177-189, Wingerchuk, D.M.,et al, 2015

Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders
JAMA Neurol 72:81-87, Flanagan, E.P.,et al, 2015

Anti-Mog Antibodies with Longitudinally Extensive Transverse Myelitis Preceded by Clippers
Neurol 84:1177-1179, Symmonds, M.,et al, 2015

Treatment Outcomes with Rituximab in 100 Patients with Neuromyelitis Optica
JAMA Neurol 72:989-995, Kim, S.H.,et al, 2015

Opportunistic Infections of the Retina in Patients with Aquaporin-4 Antibody Disease
JAMA Neurol 71:1429-1432, George, J.S.,et al, 2014

Extensive Vasogenic Edema of Anti-Aquaporin-4 Antibody-Related Brain Lesions
Mult Scler 15:1113-1117, Matsushita, T.,et al, 2013

Brain Abnormalities as an Initial Manifestation of Neuromyelitis Optica Spectrum Disorder
MSJ 17:1107-1112, Kim, W.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Two Cases of Lumbosacral Myeloradiculitis with Anti-Aquaporin-4 Antibody
Neurol 79:1826-1828, Takai, Y.,et al, 2012

Serologic Diagnosis of NMO
Neurol 78:665-671, Waters,P.J.,et al, 2012

Current Concept of Neuromyelitis Optica (NMO) and NMO Spectrum Disorders
JNNP doi:10.1136/JNNP-2012-302310, Jacob, A.,et al, 2012

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder
Multiple Sclerosis International ID 735486, Kim, W.,et al, 2012

The Differential Diagnosis of Longitudinally Extensive Transverse Myelitis
Mult Scler 18:271-285, Kitley, J.L.,et al, 2012

CSF Complements Serum for Evaluating Paraneoplastic Antibodies and NMO-IgG
Neurol 76:1108-1110, McKeon,A.,et al, 2011

Syndrome of Inappropriate Antidiuresis May Herald or Accompany Neuromyelitis Optica
Neurol 77:1644-1645, Iorio, R.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

Hiccups, Nausea, and Vomiting: Water Channels Under Attack
Lancet 375:394, Riphagen,J.,et al, 2010

Longitudinally Extensive Myelopathy in Caucasians: A West Australian Study of 26 Cases from the Perth Demyelinating Diseases Database
JNNP 81:209-212, Qiu,W.,et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Pathologic and Immunologic Profiles of a Limited Form of Neuromyelitis Optica with Myelitis
Neurol 73:1628-1637, Yanagawa,K.,et al, 2009



Showing articles 0 to 50 of 1433 Next >>